Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban